ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 53 filers reported holding ADMA BIOLOGICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,039,000 | -18.4% | 1,558,290 | 0.0% | 0.28% | -37.4% |
| Q3 2020 | $3,724,000 | -52.2% | 1,558,290 | -41.4% | 0.45% | -2.8% |
| Q2 2020 | $7,789,000 | -20.1% | 2,658,290 | -21.4% | 0.47% | -35.7% |
| Q1 2020 | $9,744,000 | -52.9% | 3,383,290 | -34.5% | 0.73% | -42.4% |
| Q4 2019 | $20,668,000 | -9.2% | 5,166,961 | +1.0% | 1.26% | -44.0% |
| Q3 2019 | $22,762,000 | +3.1% | 5,114,986 | -10.3% | 2.25% | +44.1% |
| Q2 2019 | $22,080,000 | +27.0% | 5,705,352 | +24.3% | 1.56% | +42.3% |
| Q1 2019 | $17,390,000 | +58.6% | 4,588,352 | 0.0% | 1.10% | +36.1% |
| Q4 2018 | $10,966,000 | -61.1% | 4,588,352 | +1.1% | 0.81% | -46.8% |
| Q3 2018 | $28,189,000 | +47.1% | 4,539,295 | +6.8% | 1.52% | +22.8% |
| Q2 2018 | $19,164,000 | +25.1% | 4,249,234 | +27.6% | 1.24% | -11.7% |
| Q1 2018 | $15,314,000 | +41.7% | 3,329,234 | -1.1% | 1.40% | +43.3% |
| Q4 2017 | $10,810,000 | +175.5% | 3,367,635 | +164.3% | 0.98% | +124.9% |
| Q3 2017 | $3,924,000 | -16.8% | 1,273,933 | 0.0% | 0.43% | -21.8% |
| Q2 2017 | $4,714,000 | -24.2% | 1,273,933 | 0.0% | 0.56% | -14.9% |
| Q1 2017 | $6,217,000 | -4.7% | 1,273,933 | 0.0% | 0.65% | -8.9% |
| Q4 2016 | $6,523,000 | -29.3% | 1,273,933 | 0.0% | 0.72% | -19.4% |
| Q3 2016 | $9,223,000 | +21.7% | 1,273,933 | 0.0% | 0.89% | -17.2% |
| Q2 2016 | $7,580,000 | -11.6% | 1,273,933 | +20.2% | 1.07% | -17.3% |
| Q1 2016 | $8,576,000 | +0.3% | 1,060,017 | 0.0% | 1.30% | +13.2% |
| Q4 2015 | $8,554,000 | -2.8% | 1,060,017 | +0.7% | 1.15% | -7.4% |
| Q3 2015 | $8,796,000 | -8.2% | 1,052,142 | +1.7% | 1.24% | +28.6% |
| Q2 2015 | $9,582,000 | -0.9% | 1,034,721 | +4.9% | 0.96% | +9.4% |
| Q1 2015 | $9,668,000 | -1.4% | 986,507 | +12.4% | 0.88% | -30.3% |
| Q4 2014 | $9,801,000 | +22.5% | 877,407 | +12.9% | 1.26% | +14.9% |
| Q3 2014 | $8,002,000 | +23.0% | 776,863 | +16.5% | 1.10% | +13.4% |
| Q2 2014 | $6,504,000 | – | 667,099 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,433,304 | $6,464,000 | 99.88% |
| Broadfin Capital, LLC | 3,249,829 | $14,657,000 | 2.31% |
| Stonepine Capital Management, LLC | 831,731 | $3,751,000 | 2.28% |
| Aisling Capital LLC | 3,608,171 | $16,273,000 | 2.14% |
| Consonance Capital Management LP | 4,249,234 | $19,164,000 | 1.24% |
| MORGENS WATERFALL VINTIADIS & CO INC | 375,000 | $1,691,000 | 1.20% |
| Perceptive Advisors | 6,521,102 | $29,410,000 | 0.77% |
| PURA VIDA INVESTMENTS, LLC | 325,000 | $1,466,000 | 0.59% |
| 683 Capital Management, LLC | 885,000 | $3,991,000 | 0.27% |
| ARDSLEY ADVISORY PARTNERS LP | 80,000 | $361,000 | 0.05% |